A paper published today in Environment International puts a number on something policymakers usually argue about abstractly: what would actually happen if low- and middle-income countries met the World Health Organization's 2021 air quality guidelines. The answer, for 136 countries, is about 9.4 million deaths prevented or postponed in a single year from fine particulate matter alone, and roughly 1.1 million more from nitrogen dioxide.

The team at the University of Cambridge's Institute of Metabolic Science combined pollution and population data with published exposure-response evidence, then modelled two scenarios: reaching the WHO guideline values, and reaching the looser interim targets. Even the interim targets deliver about 6.6 million fewer PM2.5-linked deaths and 435,000 fewer NO2-linked ones — a useful reminder that the first increment of cleanup carries most of the benefit.

Mortality is only part of it. Meeting the PM2.5 guideline is estimated to mean, per year, 7.3 million fewer new cases of coronary heart disease, 2.8 million fewer cases of COPD, 2.3 million fewer strokes and 1.1 million fewer cases of dementia.

The money follows the disease. Direct medical savings are put at $11.8 billion a year for coronary heart disease, $8.6 billion for dementia and $5.9 billion for stroke, with productivity gains from avoided lost work capacity of $18.1 billion for COPD, $17.9 billion for stroke and $5.3 billion for coronary heart disease.

The caveats are the usual ones for this kind of modelling, and they are not small. These are counterfactual estimates: nobody has run the experiment. The exposure-response functions are drawn from epidemiological literature that is strongest in high-income settings — not in the 136 countries studied here, precisely where local cohort data is thinnest. And everything assumes the guidelines are actually met, which requires transport, energy and urban-planning decisions that no model can deliver.

"Tackling air pollution is likely to have a huge impact on improving quality of life and reducing the number of early deaths," said Dr Annalan Navaratnam, a clinical research fellow at the institute. "For the first time, we've been able to model the potential benefits of the WHO's clean air guidelines across countries with the highest levels of outdoor air pollution."

Dr Haneen Khreis added: "Meeting the WHO's air quality guideline values will not be straightforward, but low- and middle-income countries have a critical opportunity to shape healthier futures as their populations grow and their cities expand."

Why this is a story at all: the 2021 WHO guideline is severe — an annual mean of 5 micrograms per cubic metre for PM2.5. Almost no country meets it, and many developing economies sit several times above it. So the paper's contribution is less a new finding than an arithmetic that fits into budget fights: the benefit of the first slice of cleanup is large enough that the question stops being whether clean air pays and becomes who finances the redesign.